Radius Health to repurchase $112.2 million 3% convertibles at discount

By Wendy Van Sickle

Columbus, Ohio, March 3 – Radius Health Inc. plans to repurchase $112.2 million of its 3% convertible senior notes due Sept. 1, 2024 for a total purchase price of $105.7 million, according to a news release.

The purchase price is a discount of 6% to the face value of the convertibles, and the total amount to be repurchased is about 37% of the outstanding principal amount.

The repurchase is expected to close on March 18.

Radius is a Waltham, Mass.-based biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.